The Use of Subgroup Disproportionality Analyses to Explore the Sensitivity of a Global Database of Individual Case Safety Reports to Known Pharmacogenomic Risk Variants Common in Japan

Ítems similars

• Risk Factor Considerations in Statistical Signal Detection: Using Subgroup Disproportionality to Uncover Risk Groups for Adverse Drug Reactions in VigiBase
  per: Sandberg, Lovisa, et al.
  Publicat: (2020)
• Disproportionality Analysis for Pharmacovigilance Signal Detection in Small Databases or Subsets: Recommendations for Limiting False-Positive Associations
  per: Caster, Ola, et al.
  Publicat: (2020)
• Data-Driven Identification of Adverse Event Reporting Patterns for Japan in VigiBase, the WHO Global Database of Individual Case Safety Reports
  per: Wakao, Rika, et al.
  Publicat: (2019)
• Interstitial Lung Disease as an Adverse Drug Reaction in Japan: Exploration of Regulatory Actions as a Basis for High Reporting
  per: Iwasa, Eiko, et al.
  Publicat: (2020)
• CellMinerCDB for Integrative Cross-Database Genomics and Pharmacogenomics Analyses of Cancer Cell Lines
  per: Rajapakse, Vinodh N., et al.
  Publicat: (2018)